New York Times: Could the drugs that upended diabetes and obesity benefit the brain?

The promise of help with weight loss is always alluring. But what if that solution comes with a few hidden risks?In South Africa, where obesity rates...

Several years ago, a little-known drug named Ozempic – previously used only to treat diabetes – emerged as a promising new drug for weight...

WEDNESDAY, Jan. 29, 2025 -- A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans at risk...

Scientists have developed two new imaging agents that work better than the only currently approved one for detecting tau tangles in the brain. Tau...

Scientists have discovered a potential new drug that could help people with Alzheimer’s disease by improving memory and repairing brain damage. The...

GLP1-based obesity medicines, such as Ozempic and Wegovy, have surged in popularity and become the subject of intense public debate.

A new study from Mass Eye and Ear suggests that people taking semaglutide, a drug sold as Ozempic and Wegovy, may have a higher risk of...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity,...

Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity. The dramatic effects of these drugs,...